tirzepatide and iih Tirzepatide: A First-in-class Twincretin for the Management of Type 2 Diabetes FDA grants fast track designation
Description
We prioritize your safety and tailor every treatment plan to your individual needs
Retrieved from Alyafei, A., Balfour, J., & Keyes, D
Limitations : As a case report with one patient (N=1 study), the findings are anecdotal and require corroboration through larger, controlled studies to establish broader applicability
doi: 10.1007/s13244-011-0129-9
